Ergoteles LLC Neu Base Therapeutics, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.18 - $0.3 $6,821 - $11,369	37,899 New	37,899 $7,000
Q4 2021 Feb 14, 2022	SELL	$2.6 - $4.18 $193,835 - $311,627	-74,552 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.27 - $4.76 $6,867 - $9,996	-2,100 Reduced 2.74%	74,552 $269,000
Q2 2021 Aug 12, 2021	BUY	$4.63 - $7.34 $354,898 - $562,625	76,652 New	76,652 $367,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.